Rabeprazole is an antiulcer drug in the class of proton pump inhibitors. It was developed by Eisai Co. and is marketed by Janssen-Cilag as rabeprazole sodium under the brand names AcipHex (, referring to pH) in the US and Pariet in Britain, Italy, Greece, Australia, Brazil, Canada, Japan, and Russia.